Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Tripelennamine MeSH Descriptor Data 2026


MeSH Heading
Tripelennamine
Tree Number(s)
D02.092.782.258.368.900
D03.383.725.050.920
Unique ID
D014309
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D014309
Scope Note
A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
Entry Term(s)
Azaron
Histantin
Pyribenzamine
Tripelennamine Citrate
Tripelennamine Citrate (1:1)
Tripelennamine Hydrochloride
Tripelennamine Maleate
Tripelennamine Maleate (1:1)
Tripelennamine Monohydrochloride
Vetibenzamin
Pharm Action
Histamine H1 Antagonists
Anti-Allergic Agents
Registry Numbers
3C5ORO99TY
30OC46A3J9
154-69-8
FWV8GJ56ZN
57116-36-6
58044-99-8
0
Related Numbers
154-69-8
22306-05-4
30OC46A3J9
57116-36-6
58044-99-8
6138-56-3
91-81-6
FWV8GJ56ZN
CAS Type 1 Name
1,2-Ethanediamine, N,N-dimethyl-N'-(phenylmethyl)-N'-2-pyridinyl-
Date Introduced
1966/01/01
Last Updated
2018/03/01
Tripelennamine Preferred
Tripelennamine Citrate Narrower
Tripelennamine Monohydrochloride Narrower
Tripelennamine Hydrochloride Narrower
Tripelennamine Maleate Narrower
Tripelennamine Maleate (1:1) Narrower
Pyribenzamine Narrower
Azaron Narrower
Histantin Narrower
Vetibenzamin Narrower
page delivered in 0.142s